Coronary risk stratification in patients with ischemic stroke or transient ischemic stroke attack

International Journal of Stroke

Volumn 2, Issue 3, 2007, Pages 177-183

  Touzé, Emmanuel ^a   Varenne, Olivier ^a   Calvet, David ^a   Mas, Jean Louis ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY RISK; EXERCISE TEST; FEASIBILITY STUDY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS; VASCULAR DISEASE;

CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PREVALENCE; RISK FACTORS; STROKE;

EID: 34547122491     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2007.00136.x     Document Type: Review

References (59)

1. Adams RJ, Chimowitz MI, Alpert JS et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: A scientific statement for healthcare professionals from the stroke council and the Council on clinical cardiology of the American Heart Association/American Stroke Association. Circulation 2003; 108:1278-90.
2. TouzéE, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL: Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: A systematic review and meta-analysis. Stroke 2005; 36:2748-55.
3. Mathur KS, Kashyap SK, Kumar V: Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963; 27:929-34.
4. Solberg LA, McGarry PA, Moossy J, Strong JP, Tejada C, Löken AC: Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann NY Acad Sci 1968; 149:956-73.
5. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS: Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan study. Neurology 2006; 66:641-6.
6. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349:1569-81.
7. Grotta J: Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. Stroke 1997; 28:2338-46.
8. Diener HC, Cortens M, Ford G et al. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 2000; 31:2543-51.
9. Sherman DG, Atkinson RP, Chippendale T et al. Intravenous ancrod for treatment Af acute ischemic stroke: The STAT study: a randomized controlled trial. Stroke treatment with ancrod trial. JAMA 2000; 283:2395-403.
10. Bath PM, Iddenden R, Bath FJ: Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials. Stroke 2000; 31:1770-8.
11. Bath PM, Lindenstrom E, Boysen G et al. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial. Lancet 2001; 358:702-10.
12. Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): Randomised controlled trial. Lancet 2004; 363:439-45.
13. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C: The frequency, causes and timing of death within 30 days of a first stroke: The Oxfordshire community stroke project. J Neurol Neurosurg Psychiatry 1990; 53:824-9.
14. Diener HC, Ringelstein EB, von KR et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the TOPAS trial. Therapy of patients with acute stroke (TOPAS) investigators. Stroke 2001; 32:22-9.
15. Hartmann A, Rundek T, Mast H et al. Mortality and causes of death after first ischemic stroke. The Northern Manhattan stroke study. Neurology 2001; 57:2000-5.
16. Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, O'Fallon M: Cause-specific mortality after first cerebral infarction. A population-based study. Stroke 2003; 34:1828-32.
17. Hankey GJ, Jamrozik K, Broadhurst RJ et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth community stroke study. Stroke 2000; 31:2080-6.
18. Sen S, Oppenheimer SM: Cardiac disorders and stroke. Curr Opin Neurol 1998; 11:51-6.
19. Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J: Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 1986; 17:387-90.
20. : Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998; 19:1434-503.
21. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100:1481-92.
22. Brown DL, Lisabeth LD, Roychoudhury C, Ye Y, Morgenstern LB: Recurrent stroke risk is higher than cardiac event risk after initial stroke/ transient ischemic attack. Stroke 2005; 36:1285-7.
23. van Wijk I, Kappelle LJ, van Gijn J et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: A cohort study. Lancet 2005; 365:2098-104.
24. Amarenco P, Bogousslavsky J, Callahan A III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355:549-59.
25. TouzéE, Mas JL, Röther J et al. Risk of vascular death and myocardial infarction in patients with stroke or TIA: Results from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Cerebrovasc Dis 2006; 21:55.
26. Rokey R, Rolak LA, Harati Y, Kurka N, Verani MS: Coronary artery disease in patients with cerebrovascular disease: A prospective study. Ann Neurol 1984; 16:50-3.
27. Di Pasquale G, Pinelli G, Grazi P et al. Incidence of silent myocardial ischaemia in patients with cerebral ischaemia. Eur Heart J 1988; 9:104-7.
28. Di Pasquale G, Andreoli A, Carini G et al. Noninvasive screening for silent ischemic heart disease in patients with cerebral ischemia: Use of dipyridamole-thallium myocardial imaging. Cerebrovasc Dis 1991; 1:31-7.
29. Love BB, Grover-McKay M, Biller J, Rezai K, McKay CR: Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke 1992; 23:939-45.
30. Urbinati S, Di Pasquale G, Andreoli A et al. Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing endarterectomy. Am J Cardiol 1992; 69:1166-70.
31. Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD: Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke 1997; 28:941-5.
32. Macko RF, Katzel LI, Yataco A et al. Low-velocity graded treadmill stress testing in hemiparetic stroke patients. Stroke 1997; 28:988-92.
33. Arenillas JF, Candell-Riera J, Romero-Farina G et al. Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 2005; 36:1201-6.
34. Nighoghossian N, Cakmak S, Derex L et al. Silent coronaropathy: usefulness of dobutamine stress echocardiography in ischemic stroke. Eur Neurol 2006; 56:211-6.
35. Hertzer NR, Young JR, Beven EG et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 1985; 145:849-52.
36. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P: Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007; 38:1203-1210.
37. Smith SC Jr, Amsterdam E, Balady GJ et al. Prevention conference V: beyond secondary prevention: Identifying the high-risk patient for primary prevention: Tests for silenW and inducible ischemia: writing group II. Circulation 2000; 101:E12-6.
38. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24:987-1003.
39. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-47.
40. D'Agostino RB, Russell MW, Huse DM et al. Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 2000; 139:272-81.
41. Bogousslavsky J, Van Melle G, Regli F: The lausanne stroke registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19:1083-92.
42. Grau AJ, Weimar C, Buggle F et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German stroke data bank. Stroke 2001; 32:2559-66.
43. Joakimsen O, Bonaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E: Prediction of mortality by ultrasound screening of general population for carotid stenosis. The Tromso study. Stroke 2000; 31:1871-6.
44. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke 2001; 32:2735-40.
45. Longstreth WT Jr, Bernick C, Fitzpatrick A et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001; 56:368-75.
46. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50:208-16.
47. Gates PC, Eliasziw M, Algra A, Barnett HJM, Gunton RW: For the North American symptomatic carotid endarterectomy trial group. Identifying patients with symptomatic carotid artery disease at high and low risk of severe myocardial infarction and cardiac death. Stroke 2002; 33:2413-6.
48. TouzéE, Warlow CP, Rothwell PM: Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke 2006; 37:2904-9.
49. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282:2035-42.
50. Shaaban AM, Duerinckx AJ: Wall shear stAess and early atherosclerosis: a review. Am J Roentgenol 2000; 174:1657-65.
51. Sitzer M, Puac D, Buehler A et al. Internal carotid artery angle of origin: A novel risk factor for early carotid atherosclerosis. Stroke 2003; 34:950-5.
52. Gnasso A, Irace C, Carallo C et al. In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. Stroke 1997; 28:993-8.
53. Adams GJ, Simoni DM, Bordelon CB Jr et al. Bilateral symmetry of human carotid artery atherosclerosis. Stroke 2002; 33:2575-80.
54. Vink A, Schoneveld AH, Richard W et al. Plaque burden, arterial remodeling and plaque vulnerability: Determined by systemic factors? J Am Coll Cardiol 2001; 38:718-23.
55. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 2004; 364:331-7.
56. Jackson C, Sudlow C: Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36:891-901.
57. Dewey M, Teige F, Schnapauff D et al. Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann Intern Med 2006; 145:407-15.
58. Hamon M, Biondi-Zoccai GG, Malagutti P et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: A meta-analysis. J Am Coll Cardiol 2006; 48:1896-910.
59. Eagle KA, Guyton RA, Davidoff R et al. ACC/AHA guidelines for coronary artery bypass graft surgery: ExecAtive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 1999; 100:1464-80.